Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia von Hehlmann, Rüdiger, Berger, Ute, Pfirrmann, Markus, Heimpel, Hermann, Hochhaus, Andreas, Hasford, Joerg, Kolb, Hans-Jochem, Lahaye, Tanja, Maywald, Ole, Reiter, Andreas, Hossfeld, Dieter K., Huber, Christoph, Löffler, Helmut, Pralle, Hans, Queisser, Wolfgang, Tobler, Andreas, Nerl, Christoph, Solenthaler, Max, Goebeler, Mariele E., Griesshammer, Martin, Fischer, Thomas, Kremers, Stephan, Eimermacher, Hartmut, Pfreundschuh, Michael, Hirschmann, Wolf-Dietrich, Lechner, Klaus, Wassmann, Barbara, Falge, Christiane, Kirchner, Hartmut H., Gratwohl, Alois

Volltext

Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib fail... von Fabarius, Alice, Haferlach, Claudia, Muller, Martin C, Erben, Philipp, Lahaye, Tanja, Giehl, Michelle, Frank, Oliver, Seifarth, Wolfgang, Hehlmann, Rudiger, Hochhaus, Andreas

Volltext

Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency von PESCHEN, M, LAHAYE, T, HENNIG, B, WEYL, A, SIMON, J. C, VANSCHEIDT, W

Volltext

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up von Lahaye, Tanja, Riehm, Birte, Berger, Ute, Paschka, Peter, Müller, Martin C, Kreil, Sebastian, Merx, Kirsten, Schwindel, Uwe, Schoch, Claudia, Hehlmann, Rüdiger, Hochhaus, Andreas

Volltext

Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia von Burchert, Andreas, Wölfl, Stefan, Schmidt, Manuel, Brendel, Cornelia, Denecke, Barbara, Cai, Dali, Odyvanova, Larissa, Lahaye, Tanja, Müller, Martin C., Berg, Thomas, Gschaidmeier, Harald, Wittig, Burghardt, Hehlmann, Rüdiger, Hochhaus, Andreas, Neubauer, Andreas

Volltext

Iron Deficiency Status in Polycythemia Vera Correlates Well with Bone Marrow Angiogenesis in Patients Treated with Phlebotomy von Willer, Andreas, Lahaye, Tanja, Saussele, Susanne, Hehlmann, Ruediger, Hochhaus, Andreas

Volltext

Centrosome Aberrations, Disturbed Mitotic Spindle Formation and G1 Arrest in Normal and Leukemic Cells Treated with the SRC/ABL Inhibitor Dasatinib von Fabarius, Alice, Giehl, Michelle, Kraemer, Alwin, Frank, Oliver, Mueller, Martin C., Duesberg, Peter, Lahaye, Tanja, Schoch, Claudia, Hehlmann, Rudiger, Seifarth, Wolfgang, Hochhaus, Andreas

Volltext

Dynamics of Cytogenetic Aberrations in Philadelphia Chromosome Positive and Negative Hematopoiesis during Dasatinib Therapy of Chronic Myeloid Leukemia Patients after Imatinib Fail... von Fabarius, Alice, Schoch, Claudia, Mueller, Martin C., Erben, Philipp, Lahaye, Tanja, Giehl, Michelle, Frank, Oliver, Seifarth, Wolfgang, Hehlmann, Rudiger, Hochhaus, Andreas

Volltext

BCR-ABL P-Loop Deletion Detected in Imatinib-Resistant CML Patients Corresponds to Splice Variant Associated with L248V Point Mutation, Retains BCR-ABL Kinase Activity, and Respond... von von Bubnoff, Nikolas, Erben, Philipp, Müller, Martin, Lahaye, Tanja, Schnittger, Susanne, Schlegel, Frank, Serve, Hubert, Grüneisen, Andreas, Hehlmann, Rudiger, Peschel, Christian, Duyster, Justus, Hochhaus, Andreas

Volltext

Response to Dasatinib after Imatinib Failure According to Type of Preexisting BCR-ABL Mutations von Müller, Martin C., Erben, Philipp, Schenk, Thomas, Lauber, Stephanie, Kruth, Jens, Hoffmann, Jana, Ernst, Thomas, Lahaye, Tanja, Metzgeroth, Georgia, Acevedo, Michael, Nicaise, Claude, Hehlmann, Rudiger, Hochhaus, Andreas

Volltext

Combination Treatment with Imatinib and Mitoxantrone/Etoposide Is a Suitable Preparative Regimen before Allogeneic Transplantation in Patients with Myeloid Blast Crisis of Chronic... von Fruehauf, Stefan, Topaly, Julian, Buss, Eike C., Lahaye, Tanja, Ottmann, Oliver G., Fischer, Thomas, Emmerich, Bertold, Haus, Ulrike, Hehlmann, Rudiger, Ho, Anthony D., Hochhaus, Andreas

Volltext

Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia von Brümmendorf, Tim H., Ersöz, Inci, Hartmann, Ulrike, Bartolovic, Kerol, Balabanov, Stefan, Wahl, Alexandra, Paschka, Peter, Kreil, Sebastian, Lahaye, Tanja, Berger, Ute, Gschaidmeier, Harald, Bokemeyer, Carsten, Hehlmann, Rüdiger, Dietz, Klaus, Lansdorp, Peter M., Kanz, Lothar, Hochhaus, Andreas

Volltext

Normalization of Previously Shortened Telomere Length under Treatment with Imatinib Argues against a Preexisting Telomere Length Deficit in Normal Hematopoietic Stem Cells from Pat... von BRÜMMENDORF, TIM H., ERSÖZ, INCI, HARTMANN, ULRIKE, BALABANOV, STEFAN, WOLKE, HOLGER, PASCHKA, PETER, LAHAYE, TANJA, BERNER, BIRGIT, BARTOLOVIC, KEROL, KREIL, SEBASTIAN, BERGER, UTE, GSCHAIDMEIER, HARALD, BOKEMEYER, CARSTEN, HEHLMANN, RÜDIGER, DIETZ, KLAUS, LANSDORP, PETER M., KANZ, LOTHAR, HOCHHAUS, ANDREAS

Volltext

Response and resistance in 300 patients with BCR‐ABL–positive leukemias treated with imatinib in a single center von Lahaye, Tanja, Riehm, Birte, Berger, Ute, Paschka, Peter, Müller, Martin C., Kreil, Sebastian, Merx, Kirsten, Schwindel, Uwe, Schoch, Claudia, Hehlmann, Rüdiger, Hochhaus, Andreas

Volltext

Dmg treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Commentary von GUILHOT, Francois, HEHLMANN, Rüdiger, REITER, Andreas, HOSSFELD, Dieter K, HUBER, Christoph, LÖFFLER, Helmut, PRALLE, Hans, QUEISSER, Wolfgang, TOBLER, Andreas, NERL, Christoph, SOLENTHALER, Max, GOEBELER, Mariele E, BERGER, Ute, GRIESSHAMMER, Martin, FISCHER, Thomas, KREMERS, Stephan, EIMERMACHER, Hartmut, PFREUNDSCHUH, Michael, HIRSCHMANN, Wolf-Dietrich, LECHNER, Klaus, WASSMANN, Barbara, FALGE, Christiane, KIRCHNER, Hartmut H, PTIRRMANN, Markus, GRATWOHL, Alois, HEIMPEL, Hermann, HOCHHAUS, Andreas, HASFORD, Joerg, KOLB, Hans-Jochem, LAHAYE, Tanja, MAYWALD, Ole

Volltext